WANT A PROFILE LIKE THIS?
Create my FREE Plan Or learn about other options
Hilal Ozdag
PeerJ Editor, Author & Reviewer
2,970 Points

Contributions by role

Reviewer 70
Editor 2,900

Contributions by subject area

Genetics
Virology
Gastroenterology and Hepatology
Infectious Diseases
Oncology
Biotechnology
Molecular Biology
Medical Genetics
Bioinformatics
Cell Biology
Gynecology and Obstetrics
Genomics
Hematology
Mathematical Biology
Biochemistry
Pathology
Histology
Respiratory Medicine
Computational Science
Data Mining and Machine Learning
Computational Biology
Internal Medicine
Drugs and Devices
Women's Health
Clinical Trials
Evidence Based Medicine
Immunology
Urology
Pharmacology
Translational Medicine
Surgery and Surgical Specialties
Statistics

Hilal Ozdag

PeerJ Editor, Author & Reviewer

Summary

Dr. Özdağ took her BSc in Biology from Hacettepe University Department of Biology on 1993. She then get her MSc degree in Biotechnology from the same department on 1995. Dr. Özdağ got her PhD on 2000 from Bilkent University Department of Molecular Biology and Genetics. Her PhD dissertation was on Hereditary Breast Cancer Genetics in Turkish Population. Dr. Özdağ then moved to UK for her postdoctoral studies. As a postdoctoral research associate at Prof. Caldas’s Laboratory in Cambridge University Hutchison-MRC Research Centre Dr. Özdağ worked on chromatin modifier genes in epithelial cancers.

Dr. Özdağ is leading her own research group at Ankara University Biotechnology Institute, Systems Biotechnology Advanced Research Unit (SISBIOTEK) since 2005. The team is conducting studies aiming to discover theranostic marker for colorectal cancer.

Genetics Genomics Molecular Biology Oncology

Editorial Board Member

PeerJ - the Journal of Life & Environmental Sciences

Past or current institution affiliations

Ankara University
Bilkent University
Hacettepe University
University of Cambridge

Work details

Principal Investigator

Ankara University
March 2005
Biotechnology Institute

BSc Student

Hacettepe University
October 1989 - June 1993
Department of Biology

MSc Student

Hacettepe University
October 1993 - September 1995
Department of Biology

PhD Student

Bilkent University
October 1995 - June 2000
Department of Molecular Biology and Genetics

Postdoctoral Research Associate

University of Cambridge
July 2000 - August 2004
Department of Oncology

Websites

  • ResearcherID
  • Google Scholar
  • LinkedIn

PeerJ Contributions

  • Articles 1
  • Edited 21
August 20, 2025
Transformative insights from transcriptome analysis of colorectal cancer patient tissues: identification of four key prognostic genes
Nevin Belder, Sulgun Charyyeva, Edibe Ece Abaci Oruc, Hakiimu Kawalya, Namood-e Sahar, Nader Omidvar, Berna Savas, Arzu Ensari, Hilal Ozdag
https://doi.org/10.7717/peerj.19852 PubMed 40860666

Academic Editor on

September 1, 2025
Integrative analyses of single-cell and bulk RNA sequencing to construct the tumor-associated macrophage-related prognostic signature in lung adenocarcinoma
Chaoqun Yu, Jun Chen, Jianming Deng, Hui Li, Qianru Zhuang, Bingqing Luo, Hua Ye, Hui Tian
https://doi.org/10.7717/peerj.19920
August 29, 2025
Identification and validation of PSMB7 as a novel biomarker for prognosis and immune infiltrates of lung adenocarcinoma
Yan Chen, Xin Ran, Ping Fu, Jie Ao, Guihua Zhu, Lianhua Zhao, HuaLiang Xiao
https://doi.org/10.7717/peerj.19958 PubMed 40900751
April 29, 2025
Prognostic impact of serum interleukin-6 and 17 level in patients with bladder cancer: a systematic review and meta-analysis
Liang Liu, Jun-Hui He, Yu Xiao, Dong Wei
https://doi.org/10.7717/peerj.19385 PubMed 40321822
April 14, 2025
LASSO-derived nomogram prediction model for lymph node metastasis in colorectal cancer: a retrospective analysis
Xiyun Quan, Yi Deng, Zhimin Liu, Zhenqin Gao, Huimei Yi, Ming Li
https://doi.org/10.7717/peerj.19148 PubMed 40247833
March 18, 2025
A combination of hepatic leukemia factor and circulating tumor cells serve as effective biomarkers for lung adenocarcinoma prognosis
Yaofeng Zhi, Jinhua Wu, Ronggang Li, Xuefei Chang, Silin Liu, Wenjie Lu, Mingzhu Zheng, Baoyi Liu, Jiarong Chen, Xin Zhang, Yanming Huang
https://doi.org/10.7717/peerj.19092 PubMed 40124619
January 27, 2025
Safety profile of EZH2 inhibitors for cancer: a systematic review and meta-analysis
Zhou Zhao, Xiufeng Chen, Huayang Pang, Yan Shi, Hao Sun
https://doi.org/10.7717/peerj.18871 PubMed 39886019
January 13, 2025
Unveiling the complex double-edged sword role of exosomes in nasopharyngeal carcinoma
Xueyan Huang, Yuedi Tang
https://doi.org/10.7717/peerj.18783 PubMed 39822977
June 28, 2024
Creatine kinase mitochondrial 2 promotes the growth and progression of colorectal cancer via enhancing Warburg effect through lactate dehydrogenase B
Shasha Cai, Qingqing Xia, Darong Duan, Junhui Fu, Zhenxing Wu, Zaixing Yang, Changfa Yu
https://doi.org/10.7717/peerj.17672 PubMed 38952967
June 12, 2023
Retrospective study of transcriptomic profiling identifies Thai triple-negative breast cancer patients who may benefit from immune checkpoint and PARP inhibitors
Monthira Suntiparpluacha, Jantappapa Chanthercrob, Doonyapat Sa-nguanraksa, Juthamas Sitthikornpaiboon, Amphun Chaiboonchoe, Patipark Kueanjinda, Natini Jinawath, Somponnat Sampattavanich
https://doi.org/10.7717/peerj.15350 PubMed 37334114
December 5, 2022
Upregulated TUBG1 expression is correlated with poor prognosis in hepatocellular carcinoma
Kainan Zhang, Mengsi Yu, Hui Liu, Zhao Hui, Ning Yang, Xiaojuan Bi, Li Sun, RenYong Lin, Guodong Lü
https://doi.org/10.7717/peerj.14415 PubMed 36523478
October 5, 2022
Histone H3K9 demethylase JMJD2B/KDM4B promotes osteogenic differentiation of bone marrow-derived mesenchymal stem cells by regulating H3K9me2 on RUNX2
Pan Kang, Zhiming Wu, Yuxi Huang, Zhen Luo, Shaochuan Huo, Qunqun Chen
https://doi.org/10.7717/peerj.13862 PubMed 36217382
May 19, 2022
Potential and functional prediction of six circular RNAs as diagnostic markers for colorectal cancer
Li yuan Liu, Dan Jiang, Yuliang Qu, Hongxia Wang, Yanting Zhang, Shaoqi Yang, Xiaoliang Xie, Shan Wu, Haijin Zhou, Guangxian Xu
https://doi.org/10.7717/peerj.13420 PubMed 35611168
May 10, 2022
ESR2 gene variants (rs1256049, rs4986938, and rs1256030) and their association with breast cancer risk
Martha Patricia Gallegos-Arreola, Guillermo M. Zúñiga-González, Luis E. Figuera, Ana María Puebla-Pérez, María Guadalupe Márquez-Rosales, Belinda Claudia Gómez-Meda, Mónica Alejandra Rosales-Reynoso
https://doi.org/10.7717/peerj.13379 PubMed 35573183
December 14, 2021
Comprehensive analysis of ceRNA network of ERCC4 in colorectal cancer
Huixin Hu, Songyi Liu, Aining Chu, Jing Chen, Chengzhong Xing, Jingjing Jing
https://doi.org/10.7717/peerj.12647 PubMed 34993023
September 6, 2021
Comprehensive analysis of abnormal expression, prognostic value and oncogenic role of the hub gene FN1 in pancreatic ductal adenocarcinoma via bioinformatic analysis and in vitro experiments
Xiaohua Lei, Guodong Chen, Jiangtao Li, Wu Wen, Jian Gong, Jie Fu
https://doi.org/10.7717/peerj.12141 PubMed 34567847
December 8, 2020
Polo like kinase 1 expression in cervical cancer tissues generated from multiple detection methods
Li Gao, Yu-Yan Pang, Xian-Yu Guo, Jing-Jing Zeng, Zhong-Qing Tang, Dan-Dan Xiong, Xia Yang, Ying Li, Fu-Chao Ma, Lin-Jiang Pan, Zhen-Bo Feng, Gang Chen
https://doi.org/10.7717/peerj.10458 PubMed 33354424
November 26, 2020
The m6A reader protein YTHDC2 is a potential biomarker and associated with immune infiltration in head and neck squamous cell carcinoma
Yang Li, Ji-Na Zheng, En-Hao Wang, Chan-Juan Gong, Keng-Fu Lan, XiaoJun Ding
https://doi.org/10.7717/peerj.10385 PubMed 33304653
September 1, 2020
Identification of a prognostic signature of nine metabolism-related genes for hepatocellular carcinoma
Chaozhi Tang, Jiakang Ma, Xiuli Liu, Zhengchun Liu
https://doi.org/10.7717/peerj.9774 PubMed 32953265
June 25, 2020
Searching for a signature involving 10 genes to predict the survival of patients with acute myelocytic leukemia through a combined multi-omics analysis
Haifeng Zhuang, Yu Chen, Xianfu Sheng, Lili Hong, Ruilan Gao, Xiaofen Zhuang
https://doi.org/10.7717/peerj.9437 PubMed 32617195
May 6, 2020
Identification of key genes associated with progression and prognosis for lung squamous cell carcinoma
Xiaohan Ma, Huijun Ren, Ruoyu Peng, Yi Li, Liang Ming
https://doi.org/10.7717/peerj.9086 PubMed 32411535
December 3, 2019
Overexpression of VEGF-C and MMP-9 predicts poor prognosis in Kazakh patients with esophageal squamous cell carcinoma
Jiangfen Li, Yufang Xie, Xueli Wang, Chenhao Jiang, Xin Yuan, Anzhi Zhang, Chunxia Liu, Lijuan Pang, Feng Li, Jianming Hu
https://doi.org/10.7717/peerj.8182 PubMed 31824776